Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132789) titled 'Effects of Oxycodone/Naloxone Sustained-Release Tablets on Progression-Free Survival in Patients with Cancer Pain' on Sept. 18.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai Ninth Peoples Hospital,Shanghai JiaoTong University School of Medicine
Condition:
Cancer pain
Intervention:
Group Oxy:Oral oxycodone prolonged?release tablets
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-01
Target Sample Size: Group Oxy:48;Group OXN PR:48;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=34024...